Related Experiment Video
Updated: May 15, 2025
07:28
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
40.5K
Evidence to Practice: As-Needed Inhaled Corticosteroid Therapy for Asthma Control
Ann O Nichols1, Lynne P Meadows2, Deborah D'Souza-Vazirani1
1National Association of School Nurses, Silver Spring, MD, USA.
NASN School Nurse (Print)
|April 7, 2025
Summary
School nurses can improve asthma care using symptom-based corticosteroid therapy. This approach may reduce student absences and benefit families facing challenges with daily controller medication adherence.
Area of Science:
- Pediatric Pulmonology
- School Health Nursing
Background:
- School nurses manage pediatric asthma, aligning care with current guidelines.
- Implementing new asthma management strategies can be difficult due to time and practice constraints.
Purpose of the Study:
- To review the Patient-Centered Outcomes Research Institute study on symptom-based corticosteroid therapy for mild, persistent asthma in students.
- To provide implementation guidance for school nurses.
Main Methods:
- Review of a study on symptom-based corticosteroid therapy versus daily controller therapy.
- Inclusion of National Association of School Nurses (NASN) implementation guidance.
Main Results:
- Symptom-based corticosteroid therapy is a viable option for specific student populations.
- This approach may be beneficial for students with mild, persistent asthma and adherence barriers.
Conclusions:
- School nurses can utilize symptom-based corticosteroid therapy to enhance asthma management.
- This strategy may improve student health outcomes and reduce school absenteeism.
Related Concept Videos
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
156
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
156
01:23Inhaled Medications
205
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
205
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:26COPD: Management Using Bronchodilators and Corticosteroids
144
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
144
01:17Drugs Used in Lower Respiratory Disorders: Overview
278
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
278
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
165
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
165